Global and United States Neuroblastoma Drugs Market Report & Forecast 2023-2028

Report ID: 1869501 | Published Date: Jan 2025 | No. of Page: 92 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Neuroblastoma Drugs Revenue in Neuroblastoma Drugs Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Neuroblastoma Drugs Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Neuroblastoma Drugs Market Size for the Year 2017-2028
        1.2.2 Global Neuroblastoma Drugs Market Size for the Year 2017-2028
    1.3 Neuroblastoma Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Neuroblastoma Drugs in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Neuroblastoma Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Neuroblastoma Drugs Market Dynamics
        1.4.1 Neuroblastoma Drugs Industry Trends
        1.4.2 Neuroblastoma Drugs Market Drivers
        1.4.3 Neuroblastoma Drugs Market Challenges
        1.4.4 Neuroblastoma Drugs Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Neuroblastoma Drugs by Type
    2.1 Neuroblastoma Drugs Market Segment by Type
        2.1.1 Chemotherapy
        2.1.2 Immunotherapy
        2.1.3 Others
    2.2 Global Neuroblastoma Drugs Market Size by Type (2017, 2022 & 2028)
    2.3 Global Neuroblastoma Drugs Market Size by Type (2017-2028)
    2.4 United States Neuroblastoma Drugs Market Size by Type (2017, 2022 & 2028)
    2.5 United States Neuroblastoma Drugs Market Size by Type (2017-2028)
3 Neuroblastoma Drugs by Application
    3.1 Neuroblastoma Drugs Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Clinics
        3.1.3 Others
    3.2 Global Neuroblastoma Drugs Market Size by Application (2017, 2022 & 2028)
    3.3 Global Neuroblastoma Drugs Market Size by Application (2017-2028)
    3.4 United States Neuroblastoma Drugs Market Size by Application (2017, 2022 & 2028)
    3.5 United States Neuroblastoma Drugs Market Size by Application (2017-2028)
4 Global Neuroblastoma Drugs Competitor Landscape by Company
    4.1 Global Neuroblastoma Drugs Market Size by Company
        4.1.1 Top Global Neuroblastoma Drugs Companies Ranked by Revenue (2021)
        4.1.2 Global Neuroblastoma Drugs Revenue by Player (2017-2022)
    4.2 Global Neuroblastoma Drugs Concentration Ratio (CR)
        4.2.1 Neuroblastoma Drugs Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Neuroblastoma Drugs in 2021
        4.2.3 Global Neuroblastoma Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Neuroblastoma Drugs Headquarters, Revenue in Neuroblastoma Drugs Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Neuroblastoma Drugs Headquarters and Area Served
        4.3.2 Global Neuroblastoma Drugs Companies Revenue in Neuroblastoma Drugs Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Neuroblastoma Drugs Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Neuroblastoma Drugs Market Size by Company
        4.5.1 Top Neuroblastoma Drugs Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Neuroblastoma Drugs Revenue by Players (2020, 2021 & 2022)
5 Global Neuroblastoma Drugs Market Size by Region
    5.1 Global Neuroblastoma Drugs Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Neuroblastoma Drugs Market Size by Region (2017-2028)
        5.2.1 Global Neuroblastoma Drugs Market Size by Region: 2017-2022
        5.2.2 Global Neuroblastoma Drugs Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Neuroblastoma Drugs Market Size YoY Growth 2017-2028
        6.1.2 North America Neuroblastoma Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Neuroblastoma Drugs Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Neuroblastoma Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Neuroblastoma Drugs Market Size YoY Growth 2017-2028
        6.3.2 Europe Neuroblastoma Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Neuroblastoma Drugs Market Size YoY Growth 2017-2028
        6.4.2 Latin America Neuroblastoma Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Neuroblastoma Drugs Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Neuroblastoma Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Pfizer
        7.1.1 Pfizer Company Details
        7.1.2 Pfizer Business Overview
        7.1.3 Pfizer Neuroblastoma Drugs Introduction
        7.1.4 Pfizer Revenue in Neuroblastoma Drugs Business (2017-2022)
        7.1.5 Pfizer Recent Development
    7.2 Teva Pharmaceutical
        7.2.1 Teva Pharmaceutical Company Details
        7.2.2 Teva Pharmaceutical Business Overview
        7.2.3 Teva Pharmaceutical Neuroblastoma Drugs Introduction
        7.2.4 Teva Pharmaceutical Revenue in Neuroblastoma Drugs Business (2017-2022)
        7.2.5 Teva Pharmaceutical Recent Development
    7.3 Johnson & Johnson
        7.3.1 Johnson & Johnson Company Details
        7.3.2 Johnson & Johnson Business Overview
        7.3.3 Johnson & Johnson Neuroblastoma Drugs Introduction
        7.3.4 Johnson & Johnson Revenue in Neuroblastoma Drugs Business (2017-2022)
        7.3.5 Johnson & Johnson Recent Development
    7.4 Bristol-Myers Squibb
        7.4.1 Bristol-Myers Squibb Company Details
        7.4.2 Bristol-Myers Squibb Business Overview
        7.4.3 Bristol-Myers Squibb Neuroblastoma Drugs Introduction
        7.4.4 Bristol-Myers Squibb Revenue in Neuroblastoma Drugs Business (2017-2022)
        7.4.5 Bristol-Myers Squibb Recent Development
    7.5 United Therapeutics
        7.5.1 United Therapeutics Company Details
        7.5.2 United Therapeutics Business Overview
        7.5.3 United Therapeutics Neuroblastoma Drugs Introduction
        7.5.4 United Therapeutics Revenue in Neuroblastoma Drugs Business (2017-2022)
        7.5.5 United Therapeutics Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Neuroblastoma Drugs Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Neuroblastoma Drugs Market Trends
    Table 3. Neuroblastoma Drugs Market Drivers
    Table 4. Neuroblastoma Drugs Market Challenges
    Table 5. Neuroblastoma Drugs Market Restraints
    Table 6. Global Neuroblastoma Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Neuroblastoma Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Neuroblastoma Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Neuroblastoma Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Neuroblastoma Drugs Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Neuroblastoma Drugs Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Neuroblastoma Drugs Revenue Share by Player, 2017-2022
    Table 13. Global Neuroblastoma Drugs Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Neuroblastoma Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroblastoma Drugs as of 2021)
    Table 15. Top Players of Neuroblastoma Drugs in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Neuroblastoma Drugs Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Neuroblastoma Drugs Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Neuroblastoma Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Neuroblastoma Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Neuroblastoma Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Neuroblastoma Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Neuroblastoma Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Neuroblastoma Drugs Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Neuroblastoma Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Neuroblastoma Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Neuroblastoma Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Neuroblastoma Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Neuroblastoma Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Pfizer Company Details
    Table 31. Pfizer Business Overview
    Table 32. Pfizer Neuroblastoma Drugs Product
    Table 33. Pfizer Revenue in Neuroblastoma Drugs Business (2017-2022) & (US$ Million)
    Table 34. Pfizer Recent Development
    Table 35. Teva Pharmaceutical Company Details
    Table 36. Teva Pharmaceutical Business Overview
    Table 37. Teva Pharmaceutical Neuroblastoma Drugs Product
    Table 38. Teva Pharmaceutical Revenue in Neuroblastoma Drugs Business (2017-2022) & (US$ Million)
    Table 39. Teva Pharmaceutical Recent Development
    Table 40. Johnson & Johnson Company Details
    Table 41. Johnson & Johnson Business Overview
    Table 42. Johnson & Johnson Neuroblastoma Drugs Product
    Table 43. Johnson & Johnson Revenue in Neuroblastoma Drugs Business (2017-2022) & (US$ Million)
    Table 44. Johnson & Johnson Recent Development
    Table 45. Bristol-Myers Squibb Company Details
    Table 46. Bristol-Myers Squibb Business Overview
    Table 47. Bristol-Myers Squibb Neuroblastoma Drugs Product
    Table 48. Bristol-Myers Squibb Revenue in Neuroblastoma Drugs Business (2017-2022) & (US$ Million)
    Table 49. Bristol-Myers Squibb Recent Development
    Table 50. United Therapeutics Company Details
    Table 51. United Therapeutics Business Overview
    Table 52. United Therapeutics Neuroblastoma Drugs Product
    Table 53. United Therapeutics Revenue in Neuroblastoma Drugs Business (2017-2022) & (US$ Million)
    Table 54. United Therapeutics Recent Development
    Table 55. Research Programs/Design for This Report
    Table 56. Key Data Information from Secondary Sources
    Table 57. Key Data Information from Primary Sources
List of Figures
    Figure 1. Neuroblastoma Drugs Product Picture
    Figure 2. Global Neuroblastoma Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Neuroblastoma Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. United States Neuroblastoma Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Neuroblastoma Drugs Market Size 2017-2028 (US$ Million)
    Figure 6. United States Neuroblastoma Drugs Market Share in Global 2017-2028
    Figure 7. Neuroblastoma Drugs Report Years Considered
    Figure 8. Product Picture of Chemotherapy
    Figure 9. Product Picture of Immunotherapy
    Figure 10. Product Picture of Others
    Figure 11. Global Neuroblastoma Drugs Market Share by Type in 2022 & 2028
    Figure 12. Global Neuroblastoma Drugs Market Size by Type (2017-2028) & (US$ Million)
    Figure 13. Global Neuroblastoma Drugs Market Share by Type (2017-2028)
    Figure 14. United States Neuroblastoma Drugs Market Share by Type in 2022 & 2028
    Figure 15. United States Neuroblastoma Drugs Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. United States Neuroblastoma Drugs Market Share by Type (2017-2028)
    Figure 17. Product Picture of Hospitals
    Figure 18. Product Picture of Clinics
    Figure 19. Product Picture of Others
    Figure 20. Global Neuroblastoma Drugs Market Share by Application in 2022 & 2028
    Figure 21. Global Neuroblastoma Drugs Market Size by Application (2017-2028) & (US$ Million)
    Figure 22. Global Neuroblastoma Drugs Market Share by Application (2017-2028)
    Figure 23. United States Neuroblastoma Drugs Market Share by Application in 2022 & 2028
    Figure 24. United States Neuroblastoma Drugs Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. United States Neuroblastoma Drugs Market Share by Application (2017-2028)
    Figure 26. North America Neuroblastoma Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 27. U.S. Neuroblastoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Canada Neuroblastoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Europe Neuroblastoma Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. Germany Neuroblastoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. France Neuroblastoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. U.K. Neuroblastoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Italy Neuroblastoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Russia Neuroblastoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Neuroblastoma Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 36. China Neuroblastoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Japan Neuroblastoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. South Korea Neuroblastoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. India Neuroblastoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Australia Neuroblastoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Taiwan Neuroblastoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Indonesia Neuroblastoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Thailand Neuroblastoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Malaysia Neuroblastoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Philippines Neuroblastoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Latin America Neuroblastoma Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 47. Mexico Neuroblastoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Brazil Neuroblastoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Argentina Neuroblastoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Neuroblastoma Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 51. Turkey Neuroblastoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Neuroblastoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. U.A.E Neuroblastoma Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Pfizer Revenue Growth Rate in Neuroblastoma Drugs Business (2017-2022)
    Figure 55. Teva Pharmaceutical Revenue Growth Rate in Neuroblastoma Drugs Business (2017-2022)
    Figure 56. Johnson & Johnson Revenue Growth Rate in Neuroblastoma Drugs Business (2017-2022)
    Figure 57. Bristol-Myers Squibb Revenue Growth Rate in Neuroblastoma Drugs Business (2017-2022)
    Figure 58. United Therapeutics Revenue Growth Rate in Neuroblastoma Drugs Business (2017-2022)
    Figure 59. Bottom-up and Top-down Approaches for This Report
    Figure 60. Data Triangulation
    Figure 61. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Teva Pharmaceutical
Johnson & Johnson
Bristol-Myers Squibb
United Therapeutics
Frequently Asked Questions
Neuroblastoma Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Neuroblastoma Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Neuroblastoma Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Dental Scalers

Dental Scalers market is segmented by region (country), players, by Type and by Application. Play ... Read More